• Dr. Enrico Antonio Braglia

    active (currently has mandates)
    domiciled in Vaduz
    from Lugano

    Reports for Dr. Enrico Antonio Braglia

    *displayed reports are examples
    preview

    Person dossier

    All information about the person in a compact document.
    Find out more

    Network

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Dr. Enrico Antonio Braglia

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 210830/2021 - 30.08.2021
    Categories: Change in management, Change of auditors

    Publication number: HR02-1005280264, Commercial Registry Office Ticino, (501)

    APR Applied Pharma Research Holding SA, in Balerna, CHE-467.502.231, società anonima (Nr. FUSC 60 del 27.03.2018, Pubbl. 4137055).

    Persone dimissionarie e firme cancellate:
    Reiner, Giorgio, cittadino italiano, in Como (IT), presidente, con firma individuale;
    Pettinicchio, Francesco Athos, da Mendrisio, in Vacallo, membro, con firma individuale;
    Braglia, Enrico, da Lugano, in Vaduz (LI), membro, senza diritto di firma;
    Consolida SA (CHE-100.593.003), in Chiasso, ufficio di revisione.

    Nuove persone iscritte o modifiche:
    Selvaraju, Raghuram, da Vandoeuvres, in Jersey City (US), presidente, con firma individuale;
    Galfetti, Paolo, cittadino italiano, in Cantù (IT), delegato, con firma individuale [finora: in Senna Comasco (IT)];
    Meinen, Jeremy, da Satigny, in Genève, membro, con firma individuale;
    MAZARS SA (CHE-107.861.311), in Vernier, ufficio di revisione.

    SOGC 200708/2020 - 08.07.2020
    Categories: Change in capital, Change in management

    Publication number: HR02-1004931561, Commercial Registry Office Zurich, (20)

    HeiQ Materials AG, in Schlieren, CHE-112.274.504, Aktiengesellschaft (SHAB Nr. 202 vom 18.10.2019, Publ. 1004740245).

    Statutenänderung:
    25.06.2020.

    Aktienkapital neu:
    CHF 2'765'915.00 [bisher: CHF 2'720'915.00].

    Liberierung Aktienkapital neu:
    CHF 2'765'915.00 [bisher: CHF 2'720'915.00].

    Aktien neu:
    553'183 Namenaktien zu CHF 5.00 [bisher: 544'183 Namenaktien zu CHF 5.00]. Bei der Kapitalerhöhung aus genehmigtem Aktienkapital vom 25.06.2020 werden Forderungen in der Höhe von CHF 45'000.00 verrechnet, wofür 9'000 Namenaktien zu CHF 5.00 ausgegeben werden.

    Ausgeschiedene Personen und erloschene Unterschriften:
    Braglia, Enrico, von Lugano, in Vaduz (FL), Mitglied des Verwaltungsrates, ohne Zeichnungsberechtigung;
    Odermatt, Bruno, von Dallenwil, in Emmen, mit Kollektivunterschrift zu zweien.

    SOGC 60/2018 - 27.03.2018
    Categories: Change in management

    Publication number: 4137055, Commercial Registry Office Ticino, (501)

    APR Applied Pharma Research Holding SA, in Balerna, CHE-467.502.231, società anonima (Nr. FUSC 200 del 16.10.2017, Pubbl. 3811797).

    Nuove persone iscritte o modifiche:
    Braglia, Enrico, da Lugano, in Vaduz (LI), membro, senza diritto di firma.

    Title
    Confirm